Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Goodwill & Intangibles: 2024

Historic Goodwill & Intangibles for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $15.6 million.

  • Day One Biopharmaceuticals' Goodwill & Intangibles rose 16.03% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 16.03%. This contributed to the annual value of $15.6 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Goodwill & Intangibles of $15.6 million as of FY2024.
  • Day One Biopharmaceuticals' 5-year Goodwill & Intangibles high stood at $15.6 million for FY2024, and its period low was $15.6 million during FY2024.
  • For the 1-year period, Day One Biopharmaceuticals' Goodwill & Intangibles averaged around $15.6 million, with its median value being $15.6 million (2024).